Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov model (Q43002349)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2010
edit
Language Label Description Also known as
English
Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov model
scientific article published in January 2010

    Statements

    Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov model (English)
    Mark Nuijten
    Dennis L Andress
    Steven E Marx
    Alistair S Curry
    Raimund Sterz
    1 January 2010
    545-557

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit